SCHEMBL4549435

SCHEMBL4549435

CC(C)(C)c1ccc(-c2ccc3cc(-c4ccc(-c5cccc6c5oc5ccccc56)cc4)c4ccccc4c3c2)cc1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.47
GPR84 Q9NQS5 1/20 0.41
ALDH1A1 P00352 1/20 0.40
MAPT P10636 1/20 0.40
GGPS1 O95749 1/20 0.39
PRKDC P78527 5/20 0.36
PTGES2 Q9H7Z7 1/20 0.36
S1PR1 P21453 1/20 0.33
PIK3CD O00329 1/20 0.33
PIK3CB P42338 1/20 0.33
HSP90AA1 P07900 1/20 0.33
HSP90AB1 P08238 1/20 0.33
ATM Q13315 1/20 0.32
PLA2G2A P14555 2/20 0.32
PLA2G4A P47712 2/20 0.32
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
CYP2C19 P33261 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4549424 0.93 ALOX5 (0.49) ALOX5GPR84ALDH1A1MAPTGGPS1
SCHEMBL4549428 0.88 ALOX5 (0.53) ALOX5GPR84ALDH1A1GGPS1PRKDC
SCHEMBL4549423 0.88 ALOX5 (0.53) ALOX5GPR84ALDH1A1GGPS1PRKDC
SCHEMBL4549438 0.87 ALOX5 (0.50) ALOX5GPR84ALDH1A1MAPTGGPS1
SCHEMBL4549429 0.87 ALOX5 (0.52) ALOX5GPR84ALDH1A1GGPS1PRKDC
SCHEMBL18022276 0.86 ALOX5 (0.56) ALOX5GPR84ALDH1A1MAPTGGPS1
SCHEMBL4549431 0.85 ALOX5 (0.51) ALOX5ALDH1A1MAPTGGPS1PRKDC
SCHEMBL4549433 0.85 ALOX5 (0.51) ALOX5GPR84GGPS1PRKDCPTGES2
SCHEMBL4549427 0.84 ALOX5 (0.52) ALOX5GPR84GGPS1PRKDCPTGES2
SCHEMBL9920815 0.83 ALOX5 (0.49) ALOX5GPR84ALDH1A1MAPTGGPS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9406889-B2 Phenanthrene compound, light-emitting element, light-emitting device, electronic device, and lighting device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2016-08-02 US disclosed
US-20150171333-A1 Phenanthrene Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2015-06-18 US disclosed
US-8968888-B2 Phenanthrene compound, light-emitting element, light-emitting device, electronic device, and lighting device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2015-03-03 US disclosed
US-8968888-B2 Phenanthrene compound, light-emitting element, light-emitting device, electronic device, and lighting device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2015-03-03 US disclosed
US-20120104369-A1 Phenanthrene Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-05-03 US disclosed
US-20120104369-A1 Phenanthrene Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120104369-A1 Phenanthrene Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device MC1R, NR2E3, RPS19 ALOX5 3393/4885GPR84 976/4885ALDH1A1 584/4885
US-20150171333-A1 Phenanthrene Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device MC1R, NR2E3, RPS19 ALOX5 3393/4885GPR84 976/4885ALDH1A1 584/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.